147 related articles for article (PubMed ID: 28766288)
1. In Vitro Modulation of Endogenous Alternative Splicing Using Splice-Switching Antisense Oligonucleotides.
Park JE; Cartegni L
Methods Mol Biol; 2017; 1648():39-52. PubMed ID: 28766288
[TBL] [Abstract][Full Text] [Related]
2. RNA modulation, repair and remodeling by splice switching oligonucleotides.
Kole R; Williams T; Cohen L
Acta Biochim Pol; 2004; 51(2):373-8. PubMed ID: 15218534
[TBL] [Abstract][Full Text] [Related]
3. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
4. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations.
Pros E; Fernández-Rodríguez J; Canet B; Benito L; Sánchez A; Benavides A; Ramos FJ; López-Ariztegui MA; Capellá G; Blanco I; Serra E; Lázaro C
Hum Mutat; 2009 Mar; 30(3):454-62. PubMed ID: 19241459
[TBL] [Abstract][Full Text] [Related]
5. Welcome to the splice age: antisense oligonucleotide-mediated exon skipping gains wider applicability.
McNally EM; Wyatt EJ
J Clin Invest; 2016 Apr; 126(4):1236-8. PubMed ID: 26999602
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of splice-switching oligonucleotides.
Bauman J; Jearawiriyapaisarn N; Kole R
Oligonucleotides; 2009 Mar; 19(1):1-13. PubMed ID: 19125639
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseases.
Du L; Gatti RA
J Immunol Methods; 2011 Feb; 365(1-2):1-7. PubMed ID: 21147113
[TBL] [Abstract][Full Text] [Related]
8. Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.
Errington SJ; Mann CJ; Fletcher S; Wilton SD
J Gene Med; 2003 Jun; 5(6):518-27. PubMed ID: 12797117
[TBL] [Abstract][Full Text] [Related]
9. Combination of valproic acid and morpholino splice-switching oligonucleotide produces improved outcomes in spinal muscular atrophy patient-derived fibroblasts.
Farrelly-Rosch A; Lau CL; Patil N; Turner BJ; Shabanpoor F
Neurochem Int; 2017 Sep; 108():213-221. PubMed ID: 28389270
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gene expression in mammalian nervous system through alternative pre-mRNA splicing coupled with RNA quality control mechanisms.
Yap K; Makeyev EV
Mol Cell Neurosci; 2013 Sep; 56():420-8. PubMed ID: 23357783
[TBL] [Abstract][Full Text] [Related]
11. Role of nonsense-mediated decay and nonsense-associated altered splicing in the mRNA pattern of two new α-thalassemia mutants.
Cardiero G; Scarano C; Musollino G; Di Noce F; Prezioso R; Dembech S; La Porta G; Caldora M; Bisconte MG; Colella Bisogno R; Lacerra G
Int J Biochem Cell Biol; 2017 Oct; 91(Pt B):212-222. PubMed ID: 28743675
[TBL] [Abstract][Full Text] [Related]
12. Antisense Oligonucleotides Modulating Activation of a Nonsense-Mediated RNA Decay Switch Exon in the ATM Gene.
Kralovicova J; Moreno PM; Cross NC; Pêgo AP; Vorechovsky I
Nucleic Acid Ther; 2016 Dec; 26(6):392-400. PubMed ID: 27658045
[TBL] [Abstract][Full Text] [Related]
13. More than a messenger: Alternative splicing as a therapeutic target.
Black AJ; Gamarra JR; Giudice J
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194395. PubMed ID: 31271898
[TBL] [Abstract][Full Text] [Related]
14. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.
Bruno IG; Jin W; Cote GJ
Hum Mol Genet; 2004 Oct; 13(20):2409-20. PubMed ID: 15333583
[TBL] [Abstract][Full Text] [Related]
15. Efficient in vivo manipulation of alternative pre-mRNA splicing events using antisense morpholinos in mice.
Parra MK; Gee S; Mohandas N; Conboy JG
J Biol Chem; 2011 Feb; 286(8):6033-9. PubMed ID: 21156798
[TBL] [Abstract][Full Text] [Related]
16. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides.
Taylor JK; Zhang QQ; Wyatt JR; Dean NM
Nat Biotechnol; 1999 Nov; 17(11):1097-100. PubMed ID: 10545916
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotides and RNAs as modulators of pre-mRNA splicing.
Sierakowska H; Gorman L; Kang SH; Kole R
Methods Enzymol; 2000; 313():506-21. PubMed ID: 10595376
[No Abstract] [Full Text] [Related]
18. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.
Mercatante DR; Sazani P; Kole R
Curr Cancer Drug Targets; 2001 Nov; 1(3):211-30. PubMed ID: 12188880
[TBL] [Abstract][Full Text] [Related]
19. Reversal of aberrant splicing of beta-thalassemia allele by antisense RNA in vitro and in vivo.
Zeng Y; Gu X; Chen Y; Gong L; Ren Z; Huang S
Chin Med J (Engl); 1999 Feb; 112(2):107-11. PubMed ID: 11593572
[TBL] [Abstract][Full Text] [Related]
20. Correction of aberrant pre-mRNA splicing by antisense oligonucleotides in beta-thalassemia Egyptian patients with IVSI-110 mutation.
El-Beshlawy A; Mostafa A; Youssry I; Gabr H; Mansour IM; El-Tablawy M; Aziz M; Hussein IR
J Pediatr Hematol Oncol; 2008 Apr; 30(4):281-4. PubMed ID: 18391696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
